Arvin BioHealth | شرکت آروین زیست سلامت

Arvin BioHealth (ABH) is a high-tech and knowledge-based enterprise was founded in 2015 by Dr. Hassan Morovati Khamsi. He has more than 25 years experienced in the field of clinical diagnostics and vaccine industry and as Assistant Professor at Razi Vaccine and Serum Research Institute. ABH was invested by Arvin Pazhoohan Noor (APN) holding. ABH researches and develops, manufactures, markets and distributes a broad range of innovative Medical and veterinary diagnostics test kits in point of care (POCT) tests based on Lateral Immunoassay (LFA), clinical chemistry, chemiluminescent assays (CLIA), hematology, coagulation, ELISA assays. . ABH achieved international ISO13485 Quality Management System Certification ensuring good quality, stability and reliability of the products as well as Iranian Ministry of health approval. ABH is one of the most competitive companies in the field of POCT. As a leader of POCT field in Iran and technology owner for Lateral Flow Immunoassay (LFA) and ELISA which outcome from PhD thesis of company founder. Valuing the advantage of rapid test, simple operation and high efficiency that POCT brings to IVD industry, we have built colloidal gold immunochromatography platforms and put much effort in our R&D. ABH’s COVID-19 Antigen test as one of the first products and a new category of tests for use in the ongoing pandemic in Iran. By now, we have been developing several test kits with colloidal gold immunochromatography methodology such as test for COVID-19, Drug of Morphine, Amphetamine and Methamphetamine, HCG, cTnI, etc. covering fields of cardiovascular disease, Drug of Abuse, gestation, infectious disease, etc.